side effects glp 1 receptor agonists Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus GLP-1: Genetic Variants Related to
Description
However, underlying mechanisms linking GLP-1 RAs with coronary artery disease are complex and not fully elucidated

57,684 patients: nausea RR 2.90, vomiting RR 3.60, diarrhea RR 1.97

PMC 7376989

In contrast, when Metsera responded to Novos bid, the FTC called both parties to discuss antitrust risks ( [47] ) implying regulators viewed a Novo/Novo deal (both dominant in obesity market) as worrisome

And overall prescribing rates for Zepbound in July grew at about half the pace they had been for the past year and a half, the Truveta analysis found

High medical and pharmaceutical costs are likely to continue, as are premium hikes
